US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 1.600
  • +0.060+3.90%
Close Sep 13 16:00 ET
  • 1.610
  • +0.010+0.63%
Post 19:58 ET
135.55MMarket Cap-792P/E (TTM)

Century Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Century Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 550.000K--
--2024/Q3-- / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--
--2023/Q4268.000K / 1.893M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 550.000K--
--2024/Q3-- / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--
--2023/Q4268.000K / 1.893M--

Unlock Free Earnings Estimates

Century Therapeutics Earnings Reports

  • Century Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:34 ET

  • Century Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 07:32 ET

  • Century Therapeutics | 10-K: FY2023 Annual Report

    Mar 14 07:34 ET

  • Century Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 07:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 31, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data